Bactevo

bactevo has built a unique and game-changing totally integrated medicines engine (time) to create novel therapeutics. utilising its paradigm shift in the speed, efficiency and quality of drug discovery, as well as massively enhancing safety profiling to improve clinical success, bactevo is developing breakthrough medicines for the treatment of diseases that involve defects in mitochondrial function, such as melas and lhon, as well as diseases of the central nervous system, such as parkinson’s, alzheimer’s and amyotrophic lateral sclerosis (als). further information can be found at www.bactevo.com.